Cerebral

Its online platform integrates medication management and therapy, achieved by 40% of new users obtaining a prescription within one week (2023 survey). However, it faces DEA scrutiny over controlled substance prescribing, unlike Sanvello's FDA-cleared non-drug approach. For rapid pharmacological support, Cerebral remains the fastest option on this list.